Early Defensive Mechanisms against Human Papillomavirus Infection.
Andrea Moerman-HerzogMayumi NakagawaPublished in: Clinical and vaccine immunology : CVI (2015)
Cervical cancer is the fourth most common cancer in women and is almost exclusively caused by human papillomavirus (HPV) infection. HPV is also frequently associated with other cancers arising from mucosal epithelium, including anal and oropharyngeal cancers, which are becoming more common in both men and women. Viral persistence and progression through precancerous lesion stages are prerequisites for HPV-associated cancer and reflect the inability of cell-mediated immune mechanisms to clear infections and eliminate abnormal cells in some individuals. Cell-mediated immune responses are initiated by innate pathogen sensing and subsequent secretion of soluble immune mediators and amplified by the recruitment and activation of effector T lymphocytes. This review discusses early defensive mechanisms of innate responders to natural HPV infection, their influence on response polarization, and the underappreciated role of keratinocytes in this process.
Keyphrases
- immune response
- high grade
- cervical cancer screening
- papillary thyroid
- single cell
- dendritic cells
- cell therapy
- induced apoptosis
- sars cov
- metabolic syndrome
- regulatory t cells
- oxidative stress
- signaling pathway
- polycystic ovary syndrome
- cell cycle arrest
- cell death
- candida albicans
- bone marrow
- insulin resistance
- adipose tissue
- young adults